𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeting Chronic Myeloid Leukemia Stem Cells

✍ Scribed by G. Vignir Helgason; Graham A. R. Young; Tessa L. Holyoake

Book ID
107540266
Publisher
Current Science Inc.
Year
2010
Tongue
English
Weight
221 KB
Volume
5
Category
Article
ISSN
1558-8211

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Stem-cell mobilization for autografting
Stem-cell mobilization for autografting in chronic myeloid leukemia
✍ A.M. Carella; L. Celesti; E. Lerma; A. Dejana; F. Frassoni πŸ“‚ Article πŸ“… 1997 πŸ› Elsevier Science 🌐 English βš– 602 KB

In this article, the rationale for autografting in chronic myeloid leukemia is reviewed, and alternative therapeutic approaches to the use of granulocyte-colony stimulating factor and chemotherapymobilized peripheral blood stem cells are discussed. The data from patients treated using the original I

Chronic myeloid leukemia as an immunolog
Chronic myeloid leukemia as an immunological target
✍ Lim, Seah H.; Coleman, Sharon πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 72 KB

Various clinical observations have implicated T cells in the control of chronic myeloid leukemia (CML). These observations have in recent years been supported by laboratory results indicating the presence of CML-specific T cells in the lymphocyte repertoire of both normal healthy individuals and dis

A comparison of normal and leukemic stem
A comparison of normal and leukemic stem cell biology in Chronic Myeloid Leukemia
✍ Heather G. JØrgensen; Tessa L. Holyoake πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 250 KB πŸ‘ 2 views

## Abstract Chronic Myeloid Leukemia (CML), a myeloproliferative disease of stem cell origin, is characterized by the presence of the Philadelphia (Ph) chromosome and the __bcr‐abl__ oncogene. The BCR‐ABL fusion gene product, thought to be causative in CML, has multiple effects on diverse cell func